A Systematic Review of miRNA and cfDNA as Potential Biomarkers for Liquid Biopsy in Myocarditis and Inflammatory Dilated Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12101476
Abstract: Myocarditis and inflammatory dilated cardiomyopathy are cardiac diseases leading to heart failure. Liquid biopsy is a concept of replacing traditional biopsy with specialized blood tests. The study aim was to summarize and assess the usefulness… read more here.
Keywords: myocarditis inflammatory; inflammatory dilated; biopsy; liquid biopsy ... See more keywords
Personalized Management of Myocarditis and Inflammatory Cardiomyopathy in Clinical Practice
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12020183
Abstract: Myocarditis is an inflammatory heart disease induced by infectious and non-infectious causes frequently triggering immune-mediated pathologic mechanisms leading to myocardial damage and dysfunction. In approximately half of the patients, acute myocarditis resolves spontaneously while in… read more here.
Keywords: myocarditis; personalized management; inflammatory cardiomyopathy; myocarditis inflammatory ... See more keywords
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
Sign Up to like & getrecommendations! Published in 2021 at "Cardiology Journal"
DOI: 10.5603/cj.a2021.0166
Abstract: BACKGROUND Myocarditis is frequently associated with poor prognosis as there is no evidence-based treatment. Therefore, current international recommendations indicate that a well-designed prospective trial to confirm benefits from immunosuppressive therapy is highly warranted. The aim… read more here.
Keywords: therapy; biopsy proven; inflammatory cardiomyopathy; double blind ... See more keywords